5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium)

C163H196F6Ir4N8O11S2-4 — CID 158679669

IUPAC5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium)
SMILESCC(C)(C)c1cc(-c2nccc3c(-c4ccc5nc(CC(C)(C)C(F)(F)F)oc5c4)csc23)[c-]c2ccccc12.CCC(CC)C(=O)C=C(O)C(CC)CC.CCC(CC)C(=O)C=C(O)C(CC)CC.CCC(CC)C(=O)C=C(O)C(CC)CC.CCC(CC)C(=O)C=C(O)C(CC)CC.Cc1ncc(-c2cc(-c3[c-]c4ccccc4c(C(C)(C)C)c3)ncc2C)s1.Cc1ncc(-c2ccnc(-c3[c-]c4ccccc4c(C(C)(C)C)c3)c2)o1.[2H]C([2H])(c1nc2ccc(-c3ccnc(-c4[c-]c5ccccc5c(C(C)(C)C)c4)c3)cc2o1)C(C)(C)C(F)(F)F.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/C33H28F3N2OS.C31H28F3N2O.C24H23N2S.C23H21N2O.4C13H24O2.4Ir/c1-31(2,3)25-15-21(14-19-8-6-7-9-22(19)25)29-30-23(12-13-37-29)24(18-40-30)20-10-11-26-27(16-20)39-28(38-26)17-32(4,5)33(34,35)36;1-29(2,3)24-15-22(14-21-8-6-7-9-23(21)24)26-16-20(12-13-35-26)19-10-11-25-27(17-19)37-28(36-25)18-30(4,5)31(32,33)34;1-15-13-26-22(12-20(15)23-14-25-16(2)27-23)18-10-17-8-6-7-9-19(17)21(11-18)24(3,4)5;1-15-25-14-22(26-15)17-9-10-24-21(13-17)18-11-16-7-5-6-8-19(16)20(12-18)23(2,3)4;4*1-5-10(6-2)12(14)9-13(15)11(7-3)8-4;;;;/h6-13,15-16,18H,17H2,1-5H3;6-13,15-17H,18H2,1-5H3;6-9,11-14H,1-5H3;5-10,12-14H,1-4H3;4*9-11,14H,5-8H2,1-4H3;;;;/q4*-1;;;;;;;;/i;18D2;;;;;;;;;;
InChIKeyVMJXFFVBUYENFV-JCRHTYLISA-N
MW3392.41 g/mol
LogP47.26
Rot. Bonds40

About 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium)

5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium) (PubChem CID 158679669) has the molecular formula C163H196F6Ir4N8O11S2-4 and a molecular weight of 3392.41 g/mol. Its IUPAC name is 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium).

Molecular Properties

Compound Name5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium)
PubChem CID158679669
Molecular FormulaC163H196F6Ir4N8O11S2-4
Molecular Weight3392.41 g/mol
Exact Mass3393.30
IUPAC Name5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium)
SMILESCC(C)(C)c1cc(-c2nccc3c(-c4ccc5nc(CC(C)(C)C(F)(F)F)oc5c4)csc23)[c-]c2ccccc12.CCC(CC)C(=O)C=C(O)C(CC)CC.CCC(CC)C(=O)C=C(O)C(CC)CC.CCC(CC)C(=O)C=C(O)C(CC)CC.CCC(CC)C(=O)C=C(O)C(CC)CC.Cc1ncc(-c2cc(-c3[c-]c4ccccc4c(C(C)(C)C)c3)ncc2C)s1.Cc1ncc(-c2ccnc(-c3[c-]c4ccccc4c(C(C)(C)C)c3)c2)o1.[2H]C([2H])(c1nc2ccc(-c3ccnc(-c4[c-]c5ccccc5c(C(C)(C)C)c4)c3)cc2o1)C(C)(C)C(F)(F)F.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/C33H28F3N2OS.C31H28F3N2O.C24H23N2S.C23H21N2O.4C13H24O2.4Ir/c1-31(2,3)25-15-21(14-19-8-6-7-9-22(19)25)29-30-23(12-13-37-29)24(18-40-30)20-10-11-26-27(16-20)39-28(38-26)17-32(4,5)33(34,35)36;1-29(2,3)24-15-22(14-21-8-6-7-9-23(21)24)26-16-20(12-13-35-26)19-10-11-25-27(17-19)37-28(36-25)18-30(4,5)31(32,33)34;1-15-13-26-22(12-20(15)23-14-25-16(2)27-23)18-10-17-8-6-7-9-19(17)21(11-18)24(3,4)5;1-15-25-14-22(26-15)17-9-10-24-21(13-17)18-11-16-7-5-6-8-19(16)20(12-18)23(2,3)4;4*1-5-10(6-2)12(14)9-13(15)11(7-3)8-4;;;;/h6-13,15-16,18H,17H2,1-5H3;6-13,15-17H,18H2,1-5H3;6-9,11-14H,1-5H3;5-10,12-14H,1-4H3;4*9-11,14H,5-8H2,1-4H3;;;;/q4*-1;;;;;;;;/i;18D2;;;;;;;;;;
InChIKeyVMJXFFVBUYENFV-JCRHTYLISA-N
XLogP47.26
TPSA291.74 Ų
H-Bond Donors4
H-Bond Acceptors21
Rotatable Bonds40
Heavy Atoms194
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003392.41
LogP ≤ 547.26
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium)?
The IUPAC name of 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium) (CID 158679669) is 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium).
What is the SMILES notation for 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium)?
The canonical SMILES for 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium) is CC(C)(C)c1cc(-c2nccc3c(-c4ccc5nc(CC(C)(C)C(F)(F)F)oc5c4)csc23)[c-]c2ccccc12.CCC(CC)C(=O)C=C(O)C(CC)CC.CCC(CC)C(=O)C=C(O)C(CC)CC.CCC(CC)C(=O)C=C(O)C(CC)CC.CCC(CC)C(=O)C=C(O)C(CC)CC.Cc1ncc(-c2cc(-c3[c-]c4ccccc4c(C(C)(C)C)c3)ncc2C)s1.Cc1ncc(-c2ccnc(-c3[c-]c4ccccc4c(C(C)(C)C)c3)c2)o1.[2H]C([2H])(c1nc2ccc(-c3ccnc(-c4[c-]c5ccccc5c(C(C)(C)C)c4)c3)cc2o1)C(C)(C)C(F)(F)F.[Ir].[Ir].[Ir].[Ir].
What is the InChIKey of 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium)?
The InChIKey is VMJXFFVBUYENFV-JCRHTYLISA-N. The full InChI is InChI=1S/C33H28F3N2OS.C31H28F3N2O.C24H23N2S.C23H21N2O.4C13H24O2.4Ir/c1-31(2,3)25-15-21(14-19-8-6-7-9-22(19)25)29-30-23(12-13-37-29)24(18-40-30)20-10-11-26-27(16-20)39-28(38-26)17-32(4,5)33(34,35)36;1-29(2,3)24-15-22(14-21-8-6-7-9-23(21)24)26-16-20(12-13-35-26)19-10-11-25-27(17-19)37-28(36-25)18-30(4,5)31(32,33)34;1-15-13-26-22(12-20(15)23-14-25-16(2)27-23)18-10-17-8-6-7-9-19(17)21(11-18)24(3,4)5;1-15-25-14-22(26-15)17-9-10-24-21(13-17)18-11-16-7-5-6-8-19(16)20(12-18)23(2,3)4;4*1-5-10(6-2)12(14)9-13(15)11(7-3)8-4;;;;/h6-13,15-16,18H,17H2,1-5H3;6-13,15-17H,18H2,1-5H3;6-9,11-14H,1-5H3;5-10,12-14H,1-4H3;4*9-11,14H,5-8H2,1-4H3;;;;/q4*-1;;;;;;;;/i;18D2;;;;;;;;;;.
What are the key properties of 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium)?
5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium) has a molecular weight of 3392.41 g/mol, XLogP of 47.26, 40 rotatable bonds, 4 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-5-methyl-4-pyridinyl]-2-methyl-1,3-thiazole;6-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-(1,1-dideuterio-3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;5-[2-(4-tert-butyl-1H-naphthalen-1-id-2-yl)-4-pyridinyl]-2-methyl-1,3-oxazole;6-[7-(4-tert-butyl-1H-naphthalen-1-id-2-yl)thieno[2,3-c]pyridin-3-yl]-2-(3,3,3-trifluoro-2,2-dimethylpropyl)-1,3-benzoxazole;tetrakis(3,7-diethyl-6-hydroxynon-5-en-4-one);tetrakis(iridium) is sourced from PubChem (CID 158679669), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).